A 46 kd human milk fat globule antigen
CA 2177991 A1 · Owner: Larocca, David J. · Inventors: Ceriani, Roberto L.; Larocca, David J.; Peterson, Jerry A.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A polypeptide has the antibody binding activity of the 46 Kdalton HMFG antigen and/or homology to at least of the light chains of clotting factors V and VIII and/or contains RGD and/or EGF-like segments. The polypeptide is provided as a recombinant and/or glycosylated and/or fusion protein. An antiboy has high affinity for specificity epitopes of the polypeptide of the invention. Polynucleotide segments encode the polypeptide, recombinant and fusion protein of the invention or fragments thereof and immunoassay kits comprise, the antibodies and/or polypeptides of the invention and other components. In vivo ex vivo, and in vitro methods of therapy vaccination, and diagnosis utilize the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 5, 1994. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 5, 2014.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 5, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.